Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and evaluation of a bead-based xMAP immunoassay for differential serodiagnosis of Babesia bovis and B. bigemina in cattle.

Veterinary immunology and immunopathology·2026
Same author

In Vitro Skin Models as Non-Animal Methods for Dermal Drug Development and Safety Assessment.

Pharmaceutics·2025
Same author

Combining molecular and morphological data to test the monophyly of Hypotelus Erichson and description of new species from Ecuador (Coleoptera, Staphylinidae, Piestinae).

Zootaxa·2025
Same author

Pesticide exposome reveals oxidative stress and immune response disruptions in occupationally exposed women with breast cancer.

Scientific reports·2025
Same author

Human cerebral organoids: Complex, versatile, and human-relevant models of neural development and brain diseases.

Neural regeneration research·2025
Same author

Design and development of multiepitope chimeric antigens by bioinformatic and bacterial based recombinant expression methods, with potential application for bovine tuberculosis serodiagnosis.

Veterinary immunology and immunopathology·2024
Same journal

Analysis of strength degradation of coal and rock masses and stability of mined areas under long term immersion environment.

PloS one·2026
Same journal

Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.

PloS one·2026
Same journal

Preparation and physicochemical characterization of a biodegradable chitosan/carboxymethyl cellulose hydrogel synthesized in NaOH/urea medium.

PloS one·2026
Same journal

Action-guilt, survivor-guilt, and depression in combat-related PTSD.

PloS one·2026
Same journal

Explainable machine learning for predicting activities of daily living at discharge in stroke patients: A retrospective study using SHAP interpretability.

PloS one·2026
Same journal

Deep learning based two-way feature depiction model for brain tumor detection.

PloS one·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

A novel hepatitis C virus genotyping method based on liquid microarray.

Cesar A B Duarte1, Leonardo Foti, Sueli M Nakatani

  • 1Instituto Carlos Chagas-Fundação Oswaldo Cruz, Curitiba, Brazil.

Plos One
|September 24, 2010
PubMed
Summary
This summary is machine-generated.

A new liquid microarray method accurately genotypes Hepatitis C Virus (HCV), crucial for effective treatment planning. This reliable platform shows high concordance with existing methods for HCV genotyping.

More Related Videos

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Experiment Videos

Last Updated: Jun 8, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Area of Science:

  • Virology
  • Molecular Diagnostics
  • Genetics

Background:

  • Hepatitis C Virus (HCV) treatment efficacy is genotype-dependent, necessitating accurate genotyping methods.
  • Current genotyping assays may have limitations in sensitivity and specificity for certain subtypes.

Purpose of the Study:

  • To introduce and evaluate a novel liquid microarray assay for Hepatitis C Virus (HCV) genotyping.
  • To assess the performance of the liquid microarray method against a standard assay for HCV genotyping.

Main Methods:

  • Development of a liquid microarray assay targeting the 5'UTR and NS5B regions of HCV.
  • Testing of 78 patient plasma samples previously genotyped using the Versant™ HCV Genotype Assay LiPA.

Main Results:

  • The liquid microarray successfully genotyped 95% (74/78) of samples with 100% concordance for genotype determination.
  • High concordance was observed for subtypes 3a and 2b; subtype 2c was identified to genotype level.
  • The method demonstrated reliability for identifying major genotype 1 subtypes, though with varying accuracy compared to the reference assay.

Conclusions:

  • Liquid microarray technology offers a reliable and promising platform for HCV genotyping, comparable to established methods.
  • This assay's ability to detect recombination and potential adaptation for other viruses makes it valuable for clinical diagnostics.
  • Accurate HCV genotyping is vital for guiding treatment strategies and improving patient outcomes.